RE: Simultaneous drug and metabolite POPPK
Mike,
This depends on the purpose of the modeling and the information
available. Usually, we only have Parent and Met concentration data after
oral administration, therefore, we can't estimate the true disposition
parameters. We can get CL/F and V/F for parent, but we can get nothing
more than apparent Production rate constant and Elimination rate
constant for Met. In this case, converting the data to micromolar unit
or not is not critical.
e.g.
Let's begin from the differential equation below:
DADT(3)=KMP(iv)*A(2)-KME*A(3)
Eq 1
where A(2) is the amount of parent (mg), A(3) is the amount of
metabolite (mg). KmP is the production rate of the metabolite.
Because the distribution volume of Met (V3) is unobtainable (no IV data
of Met), we have to convert dA/dt to dC/dt and divide both sides of Eq 1
by V3 as follows:
DADT(3)/V3=KMP(iv)*A(2)/V3-KME*A(3)/V3
Eq 2
In NONMEM, we coded this as follows:
DADT(3)=KMP *A(2)/V2-KME*A(3)
Eq 3
Please note that DADT(3) in Eq 3, actually, is dC3/dt (a rate of
concentration instead of amount), and KMP in Eq 3 = KMP(iv) x V2/V3 in
Eq 1. In other words, KMP is a composite parameter of both volumn ratio
and molecular weight ratio.
If there are IV data for both parent and metabolite after
administrations of parent and metabolite seperately, the true
disposition parameters can be estimated for both. By converting the
concentration unit to molar, we can estimate formation fraction of
parent to metabolite.
Jun Shi
Clinical Pharmacology and Drug Dynamics
Forest Research Institute
Rm18-35
Harborside Financial Center-Plaza V
Jersey City, NJ 07311
Tel: 201-427-8044
Fax: 201-427-8498
Email: [EMAIL PROTECTED]
-----Original Message-----
Quoted reply history
From: [EMAIL PROTECTED]
[mailto:[EMAIL PROTECTED] On Behalf Of
[EMAIL PROTECTED]
Sent: Tuesday, February 13, 2007 9:02 AM
To: Nmusers (E-mail); [EMAIL PROTECTED]
Subject: RE: [NMusers] Simultaneous drug and metabolite POPPK
I have a question for those who submitted these two examples -
Did you transform the data into micromolar quantities? It is not clear
from the examples. I have not done much parent/metabolite modeling (just
lucky I guess) but it seems to me that one would have to work in molar
units for these models to be valid. Can someone comment on this?
Mike
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Michael J. Fossler, Pharm. D., Ph. D., F.C.P.
Director
Clinical Pharmacokinetics, Modeling & Simulation
GlaxoSmithKline
(610) 270 - 4797
FAX: (610) 270-5962
Cell: (443) 350-1194
[EMAIL PROTECTED]
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~